AAIS
RMD icon

ABN AMRO Investment Solutions’s ResMed RMD Stock Holding History

ABN AMRO Investment Solutions’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Buy
8,261
+1,491
+22% +$309K 0.01% 442
2026
Q1 		$1.52M Buy
6,770
+880
+15% +$219K 0.02% 394
2025
Q4 		$1.42M Buy
5,890
+4,633
+369% +$1.18M 0.02% 368
2025
Q3 		$344K Sell
1,257
-5,427
-81% -$1.48M 0.01% 374
2025
Q2 		$1.72M Buy
6,684
+5,427
+432% +$1.29M 0.03% 260
2025
Q1 		$281K Sell
1,257
-399
-24% -$93.1K 0.01% 386
2024
Q4 		$379K Sell
1,656
-41
-2% -$9.87K 0.01% 386
2024
Q3 		$414K Buy
1,697
+171
+11% +$38.2K 0.01% 406
2024
Q2 		$292K Buy
+1,526
New +$310K 0.01% 430
2023
Q4 		– Sell
-11,947
Closed -$1.77M – 430
2023
Q3 		$1.77M Buy
+11,947
New +$2.16M 0.03% 257

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ABN AMRO Investment Solutions's RMD Position: Q2 2026 in Review

ABN AMRO Investment Solutions increased its ResMed (RMD) stake by 22% in Q2 2026, buying an estimated $309K and bringing the position to 8,261 shares worth $1.61M. The position accounts for 0.01% of the portfolio, ranked #442.

ABN AMRO Investment Solutions first reported a position in RMD in Q3 2023 and has held it in 10 quarters since. The position peaked at $1.77M in Q3 2023. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • ABN AMRO Investment Solutions held 8,261 shares of ResMed worth $1.61M as of Q2 2026.
  • ABN AMRO Investment Solutions bought 1,491 ResMed shares in Q2 2026, an estimated $309K.
  • ResMed made up 0.01% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #442 holding.
  • ABN AMRO Investment Solutions first reported a position in ResMed in Q3 2023 and has held it in 10 quarters since.
  • ABN AMRO Investment Solutions's ResMed position peaked at $1.77M in Q3 2023.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.